Table 1.
Characteristics of studies describing the prevalence and incidence of colonization with carbapenem resistant K. pneumoniae
| Authors | Positive | Sample size | Prevalence | Country | Study design | Type of patient | Ward | Site of sample | Genes |
|---|---|---|---|---|---|---|---|---|---|
| Akturk [32] | 85 | 2805 | 0.03 | Turkey | Case-control | Admitted | NICU & PICU | Rectal swab | |
| Al Fadhi [33] | 7 | 590 | 0.01 | Kuwait | Cohort | Admitted + community | M/S ICU (adult) | Rectal swab | OXA-181, KPC-2, VIM-1, NDM-5 |
| Antony [34] | 1 | 154 | 0.01 | India | Cross-sectional | Community | Rectal swab | NDM-1 | |
| Atterby [35] | 2 | 307 | 0.01 | Cambodia | Cross-sectional | Community | community | Rectal swab | OXA-48 |
| Baraniak [36] | 110 | 17945 | 0.01 | Europe & Israel | Cohort | Admitted | ICU, RU | Rectal swab | KPC-2, KPC-3 |
| Barbadoro [37] | 45 | 2478 | 0.02 | Italy | Case-control | On Admission | Rectal swab | KPC, VIM | |
| Dubby [38] | 21 | 299 | 0.07 | Israel | Cohort | On admission | ICU | Rectal swab | |
| Errico [39] | 58 | 680 | 0.09 | Italy | Cohort | Admitted | Transplant | Rectal swab | KPC |
| Ghaith [40] | 19 | 100 | 0.19 | Egypt | Cross-sectional | Admitted | ICU | Rectal swab | NDM-1, VIM, OXA-48, |
| Giannella [41] | 11 | 237 | 0.05 | Italy | Cohort | On admission | Transplant | Rectal swab | |
| Giannella [42] | 38 | 553 | 0.07 | Italy | Cohort | On admission | Transplant | Rectal swab | |
| Girlich [43] | 7 | 77 | 0.09 | Morocco | Cross-sectional | Admitted | Rectal swab | OXA-48 | |
| Kang [44] | 16 | 833 | 0.02 | Korea | Case control | On admission | EICU | Rectal swab | KPC |
| Kiddee [45] | 9 | 275 | 0.03 | Thailand | Cohort | On admission | ICU | Rectal swab | NDM |
| Kizilates [46] | 11 | 168 | 0.07 | Turkey | Cross-sectional | On admission | Rectal swab | OXA-48, NDM | |
| Liu [47] | 42 | 704 | 0.06 | China | Cross-sectional | On admission | ICU | Rectal swab | KPC, NDM, IMP |
| Mammina [48] | 31 | 391 | 0.08 | Italy | Cohort | On admission | ICU | Rectal swab | KPC |
| Maseda [49] | 41 | 254 | 0.16 | Spain | Cross-sectional | On admission | SICU | Rectal swab | OXA-48, |
| Mohan [50] | 9 | 232 | 0.04 | India | Cross-sectional | Admitted | Fecal sample | NDM-1, VIM | |
| Ohno [51] | 2 | 1487 | 0.00 | Japan | Cross-sectional | Admitted | Fecal sample | ||
| Pan [52] | 12 | 880 | 0.01 | China | Cross-sectional | On admission | Fecal sample | NDM-1, NDM-5, KPC-2, IMP-4 | |
| Papadimitriou [53] | 40 | 442 | 0.09 | Greece | Cross-sectional | On admission | ICU | Rectal swab | |
| Prasa d[54] | 46 | 301 | 0.15 | USA | Cross-sectional | Admitted | LTCF | Rectal swab | KPC-2, KPC-3 |
| Qin [55] | 37 | 243 | 0.15 | China | Cohort | On admission | ICU | Rectal swab | KPC-2 |
| Rios [56] | 4 | 501 | 0.01 | Spain | Cross-sectional | Admitted + outpatient | Rectal swab | KPC-2, OXA-48 | |
| Salamao [57] | 46 | 676 | 0.07 | Brazil | Cross-sectional | On admission | Rectal swab | ||
| Salazar-Ospina [58] | 5 | 210 | 0.02 | Colombia | Cohort | Admitted | Rectal swab | ||
| Saseedharan [59] | 12 | 54 | 0.22 | India | Cross-sectional | On admission | ICU | Rectal swab | KPC, NDM, VIM, IMP |
| Shu [60] | 42 | 202 | 0.21 | China | Cross-sectional | Admitted | ICU | Rectal swab | KPC-2 |
| Tran [61] | 260 | 2233 | 0.12 | Vietnam | Cross-sectional | Admitted | Admitted to hospital | Rectal swab | |
| Wiener [62] | 16 | 298 | 0.05 | Israel | Case-control | Admitted | Rectal swab | ||
| Xu [63] | 25 | 1052 | 0.02 | China | Cross-sectional | Admitted | Rectal swab | NDM-5, KPC-2, IMP-4 |